CLINICAL_TRIALS
trial_result
· 2018-08-14
Clinical Trial Update: A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome [Phase 3]
Summary
Phase 3 trial evaluating duloxetine in adolescents with juvenile primary fibromyalgia syndrome completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2018-08-14